NCT03315793View on ClinicalTrials.gov

A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

149

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

November 8, 2019

Study Completion Date

November 8, 2019

Conditions

Depressive Disorder

Interventions

DRUG

Duloxetine Hydrochloride

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (1)

541-0045

Shionogi, Osaka

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Eli Lilly and Company

INDUSTRY

lead

Shionogi

INDUSTRY